Collagenase 3 production by human osteoarthritic chondrocytes in response to growth factors and cytokines is a function of the physiologic state of the cells

Arthritis and Rheumatism

Volumn 42, Issue 6, 1999, Pages 1147-1158

  Tardif, Ginette ^a   Pelletier, Jean Pierre ^a   Dupuis, Martine ^a   Geng, ChangShan ^a   Cloutier, Jean Marie ^a   Martel Pelletier, Johanne ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGENASE; COLLAGENASE 1; COLLAGENASE 3; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; PARATHYROID HORMONE; PHORBOL MYRISTATE; PHOSPHOLIPASE A2; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ARTICLE; CARTILAGE CELL; CELL FUNCTION; CONTROLLED STUDY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033002392     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199906)42:6<1147::AID-ANR11>3.0.CO;2-Y     Document Type: Article

References (53)

1. Eyre DR, Wu JJ. Type XI or 1α2α3α collagen. In: Mayne R, Burgeson RE, editors. Structure and functions of collagen types. New York: Academic Press; 1987. p. 261-81.
2. Mayne R. Cartilage collagens: what is their function, and are they involved in articular disease? Arthritis Rheum 1989;32:241-6.
3. Ayad S, Marriott A, Morgan K, Grant ME. Bovine cartilage types VI and IX collagens: characterization of their forms in vivo. Biochem J 1989;262:753-61.
4. Van der Rest M, Mayne R. Type IX collagen. In: Mayne R, Burgeson RE, editors. Structure and functions of collagen types. New York: Academic Press; 1987. p. 195-221.
5. Schmid TM, Linsenmayer TF. Type X collagen. In: Mayne R, Burgeson RE, editors. Structure and functions of collagen types. New York: Academic Press; 1987. p. 223-57.
6. Eyre DR, Wu JJ, Apone S. A growing family of collagens in articular cartilage: identification of 5 genetically distinct types. J Rheumatol 1987;14:25-7.
7. Pelletier JP, Martel-Pelletier J, Howell DS. Etiopathogenesis of osteoarthritis. In: Koopman WJ, editor. Arthritis and allied conditions: a textbook of rheumatology. 13th ed. Baltimore: Williams & Wilkins; 1997. p. 1969-84.
8. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-54.
9. Imai K, Ohta S, Matsumoto T, Fujimoto N, Sato H, Seiki M, et al. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage. Am J Pathol 1997;151:245-56.
10. Büttner FH, Chubinskaya S, Margerie D, Huch K, Flechtenmacher J, Cole AA, et al. Expression of membrane type 1 matrix metalloproteinase in human articular cartilage. Arthritis Rheum 1997;40:704-9.
11. Pelletier J-P, Martel-Pelletier J, Howell DS, Ghandur-Mnaymneh L, Enis JE, Woessner JF Jr. Collagenase and collagenolytic activity in human osteoarthritic cartilage. Arthritis Rheum 1983;26:63-8.
12. Dodge GR, Poole RA. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin-1. J Clin Invest 1989;83:647-61.
13. Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994;93:1722-32.
14. Chubinskaya S, Huch K, Mikecz K, Cs-Szabo G, Hasty KA, Kuettner KE, et al. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1β in human cartilage from knee and ankle joints. Lab Invest 1996;74:232-40.
15. Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes: a role in osteoarthritis. J Clin Invest 1996;97:2011-9.
16. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996;97:761-8.
17. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272: 2446-51.
18. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996;271:1544-50.
19. Knauper V, Cowell S, Smith B, Lopez-Otin C, O'Shea M, Morris H, et al. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997;272:7608-16.
20. Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation: evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996;271:17124-31.
21. Johansson N, Saarialho-Kere U, Airola K, Herva R, Nissinen L, Westermarck J, et al. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn 1997;208:387-97.
22. Stahle-Backdahl M, Sandstedt B, Bruce K, Lindahl A, Jimenez MG, Vega JA, et al. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab Invest 1997;76:717-28.
23. Johansson N, Airola K, Grenman R, Kariniemi AL, Saarialho-Kere U, Kahari VM. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 1997;151:499-508.
24. Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994;269:16766-73.
25. Moldovan F, Pelletier J-P, Hambor J, Cloutier J-M, Martel-Pelletier J. Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor β. Arthritis Rheum 1997;40:1653-61.
26. Fernandes JC, Martel-Pelletier J, Lascau-Coman V, Moldovan F, Jovanovic D, Raynauld JP, et al. Collagenase-1 and collagenase-3 synthesis in early experimental osteoarthritic canine cartilage: an immunohistochemical study. J Rheumatol 1998;8:1585-94.
27. Vaalamo M, Mattila L, Johansson N, Kariniemi AL, Karjalainen-Lindsberg ML, Kahari VM, et al. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol 1997;109:96-101.
28. Tardif G, Pelletier JP, Dupuis M, Hambor JE, Martel-Pelletier J. Cloning, sequencing and characterization of the 5′-flanking region of the human collagenase-3 gene. Biochem J 1997;323:13-6.
29. Pendas AM, Balbin M, Llano E, Jimenez MG, Lopez-Otin C. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP-13). Genomics 1997;40:222-33.
30. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 1987;49: 729-39.
31. Vincenti MP, White LA, Schroen DJ, Benbow U, Brinckerhoff CE. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability. Crit Rev Eukaryot Gene Expr 1996;6:391-411.
32. Nguyen Q, Mort JS, Roughley PJ. Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage. J Clin Invest 1992;89:1189-97.
33. Wolfe GC, MacNaul KL, Buechel FF, McDonnell J, Hoerrner LA, Lark MW, et al. Differential in vivo expression of collagenase messenger RNA in synovium and cartilage: quantitative comparison with stromelysin messenger RNA levels in human rheumatoid art 'ritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis. Arthritis Rheum 1993;36:1540-7.
34. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
35. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76: 4350-4.
36. Lafeber FPJG, van Roy HL, van der Kraan PM, van den Berg WB, Bijlsma JW. Transforming growth factor-β predominantly stimulates phenotypically changed chondrocytes in osteoarthritic human cartilage. J Rheumatol 1997;24:536-42.
37. Martel-Pelletier J, Hilal G, Pelletier J-P, Ranger P, Lajeunesse D. Evidence for increased metabolic activity in human osteoarthritic subchondral bone explants [abstract]. Arthritis Rheum 1997;40 Suppl 9:S182.
38. Massagué J, Hata A, Liu F. TGF-β signalling through the Smad pathway. Trends Cell Biol 1997;7:187-92.
39. Atfi A, Djelloul S, Chastre E, Davis R, Gespach C. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor β-mediated signaling. J Biol Chem 1997;272:14429-32.
40. Mauviel A, Chung KY, Agarwal A, Tamai K, Uitto J. Cell-specific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor-β in fibroblasts and keratinocytes. J Biol Chem 1996;271:10917-23.
41. Uria JA, Jimenez MG, Balbin M, Freije JMP, Lopez-Otin C. Differential effects of transforming growth factor-β on the expression of collagenase-1 and collagenase-3 in human fibroblasts. J Biol Chem 1998;273:9769-77.
42. Kerr LD, Miller DB, Matrisian LM. TGF-β 1 inhibition of transin/strometysin gene expression is mediated through a Fos binding sequence. Cell 1990;61:267-78.
43. Matrisian LM, Ganser GL, Kerr LD, Pelton RW, Wood LD. Negative regulation of gene expression by TGF-β. Mol Reprod Dev 1992;32:111-20.
44. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, et al. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature 1997;389:631-5.
45. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, et al. The MAD-related protein Smad7 associates with the TGF β receptor and functions as an antagonist of TGF β signaling. Cell 1997;89:1165-73.
46. Doré S, Pelletier J-P, Di Battista JA, Tardif G, Brazeau P, Martel-Pelletier J. Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation: possible role of IGF-1-binding proteins. Arthritis Rheum 1994;37:253-63.
47. Tardif G, Reboul P, Pelletier J-P, Geng C, Cloutier J-M, Martel-Pelletier J. Normal expression of type I insulin-like growth factor receptor by human osteoarthritic chondrocytes with increased expression and synthesis of insulin-like growth factor binding proteins. Arthritis Rheum 1996;39:968-78.
48. Dayer JM. Cytokines and anti-cytokines in inflammatory rheumatism. Rev Rhum 1994;61:173S-80S.
49. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Immunology 1995;84:536-42.
50. Lacraz S, Nicod L, Galve-de Rochemonteix B, Baumberger C, Dayer JM, Welgus HG. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest 1992;90:382-8.
51. Jovanovic D, Pelletier JP, Alaaeddine N, Mineau F, Geng C, Ranger P, et al. Effect of IL-13 on cytokines, cytokine receptors and inhibitors on human osteoarthritic synovium and synovial fibroblasts. Osteoarthritis Cartilage 1998;6:40-9.
52. Lentsch AB, Shanley TP, Sarma V, Ward PA. In vivo suppression of NF-κB and preservation of IκBα by interleukin-10 and interleukin-13. J Clin Invest 1997;100:2443-8.
53. O'Banion MK, Sadowski HB, Winn V, Young DA. A serum-and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 1991;266:23261-7.